MRSN MEXC RealStocks
Own real MRSN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 10:30:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Mersana Therapeutics, Inc. (MRSN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Mersana Therapeutics, Inc. (MRSN) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing MRSN before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Mersana Therapeutics, Inc. (MRSN) moved from $29.01 to $29.08, representing a gain of 0.25% ($0.07).
The stock traded between $28.11 and $30.39 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 219.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 102 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mersana Therapeutics, Inc. (MRSN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRSN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between MRSN shares and USD.
MRSN Shares to USD
1.00 MRSN shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.